vs

Side-by-side financial comparison of NU SKIN ENTERPRISES, INC. (NUS) and Orion S.A. (OEC). Click either name above to swap in a different company.

Orion S.A. is the larger business by last-quarter revenue ($459.5M vs $320.6M, roughly 1.4× NU SKIN ENTERPRISES, INC.). NU SKIN ENTERPRISES, INC. runs the higher net margin — 0.6% vs -2.2%, a 2.7% gap on every dollar of revenue. On growth, Orion S.A. posted the faster year-over-year revenue change (-3.8% vs -12.0%). Over the past eight quarters, Orion S.A.'s revenue compounded faster (-1.9% CAGR vs -14.5%).

Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.

Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.

NUS vs OEC — Head-to-Head

Bigger by revenue
OEC
OEC
1.4× larger
OEC
$459.5M
$320.6M
NUS
Growing faster (revenue YoY)
OEC
OEC
+8.2% gap
OEC
-3.8%
-12.0%
NUS
Higher net margin
NUS
NUS
2.7% more per $
NUS
0.6%
-2.2%
OEC
Faster 2-yr revenue CAGR
OEC
OEC
Annualised
OEC
-1.9%
-14.5%
NUS

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
NUS
NUS
OEC
OEC
Revenue
$320.6M
$459.5M
Net Profit
$1.8M
$-9.9M
Gross Margin
66.9%
17.2%
Operating Margin
34.4%
2.5%
Net Margin
0.6%
-2.2%
Revenue YoY
-12.0%
-3.8%
Net Profit YoY
-208.8%
EPS (diluted)
$0.04
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NUS
NUS
OEC
OEC
Q1 26
$320.6M
$459.5M
Q4 25
$370.3M
$411.7M
Q3 25
$364.2M
$450.9M
Q2 25
$386.1M
$466.4M
Q1 25
$364.5M
$477.7M
Q4 24
$445.6M
$434.2M
Q3 24
$430.1M
$463.4M
Q2 24
$439.1M
$477.0M
Net Profit
NUS
NUS
OEC
OEC
Q1 26
$1.8M
$-9.9M
Q4 25
$14.5M
Q3 25
$17.1M
$-67.1M
Q2 25
$21.1M
$9.0M
Q1 25
$107.5M
$9.1M
Q4 24
$-36.1M
Q3 24
$8.3M
$-20.2M
Q2 24
$-118.3M
$20.5M
Gross Margin
NUS
NUS
OEC
OEC
Q1 26
66.9%
17.2%
Q4 25
70.7%
18.9%
Q3 25
70.5%
19.0%
Q2 25
68.8%
21.1%
Q1 25
67.8%
20.5%
Q4 24
62.7%
20.6%
Q3 24
70.1%
23.2%
Q2 24
70.0%
23.0%
Operating Margin
NUS
NUS
OEC
OEC
Q1 26
34.4%
2.5%
Q4 25
6.3%
4.3%
Q3 25
5.9%
-11.9%
Q2 25
8.0%
6.9%
Q1 25
-2.7%
6.5%
Q4 24
-11.9%
5.4%
Q3 24
4.2%
-3.3%
Q2 24
-28.6%
8.7%
Net Margin
NUS
NUS
OEC
OEC
Q1 26
0.6%
-2.2%
Q4 25
3.9%
Q3 25
4.7%
-14.9%
Q2 25
5.5%
1.9%
Q1 25
29.5%
1.9%
Q4 24
-8.1%
Q3 24
1.9%
-4.4%
Q2 24
-26.9%
4.3%
EPS (diluted)
NUS
NUS
OEC
OEC
Q1 26
$0.04
$-0.18
Q4 25
$0.27
$-0.36
Q3 25
$0.34
$-1.20
Q2 25
$0.43
$0.16
Q1 25
$2.14
$0.16
Q4 24
$-0.73
$0.31
Q3 24
$0.17
$-0.35
Q2 24
$-2.38
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NUS
NUS
OEC
OEC
Cash + ST InvestmentsLiquidity on hand
$198.7M
$50.5M
Total DebtLower is stronger
$223.6M
Stockholders' EquityBook value
$794.1M
$379.5M
Total Assets
$1.4B
$1.9B
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NUS
NUS
OEC
OEC
Q1 26
$198.7M
$50.5M
Q4 25
$239.8M
$60.7M
Q3 25
$253.0M
$51.3M
Q2 25
$265.4M
$42.6M
Q1 25
$213.6M
$37.5M
Q4 24
$198.0M
$44.2M
Q3 24
$237.8M
$53.2M
Q2 24
$232.9M
$34.2M
Total Debt
NUS
NUS
OEC
OEC
Q1 26
$223.6M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
NUS
NUS
OEC
OEC
Q1 26
$794.1M
$379.5M
Q4 25
$805.2M
$384.6M
Q3 25
$799.8M
$401.8M
Q2 25
$787.8M
$466.5M
Q1 25
$754.0M
$466.1M
Q4 24
$651.5M
$474.9M
Q3 24
$706.9M
$476.3M
Q2 24
$686.2M
$503.9M
Total Assets
NUS
NUS
OEC
OEC
Q1 26
$1.4B
$1.9B
Q4 25
$1.4B
$1.9B
Q3 25
$1.4B
$2.0B
Q2 25
$1.4B
$2.0B
Q1 25
$1.4B
$2.0B
Q4 24
$1.5B
$1.9B
Q3 24
$1.6B
$2.0B
Q2 24
$1.6B
$1.9B
Debt / Equity
NUS
NUS
OEC
OEC
Q1 26
0.28×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NUS
NUS
OEC
OEC
Operating Cash FlowLast quarter
$-12.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NUS
NUS
OEC
OEC
Q1 26
$-12.4M
Q4 25
$16.6M
$92.9M
Q3 25
$27.5M
$68.8M
Q2 25
$35.8M
$53.7M
Q1 25
$389.0K
$400.0K
Q4 24
$25.8M
$94.5M
Q3 24
$31.4M
$-30.9M
Q2 24
$51.2M
$29.3M
Free Cash Flow
NUS
NUS
OEC
OEC
Q1 26
Q4 25
$5.9M
$44.2M
Q3 25
$17.6M
$27.9M
Q2 25
$35.8M
$11.5M
Q1 25
$-13.2M
$-28.8M
Q4 24
$13.2M
$23.5M
Q3 24
$22.8M
$-78.8M
Q2 24
$43.1M
$-25.4M
FCF Margin
NUS
NUS
OEC
OEC
Q1 26
Q4 25
1.6%
10.7%
Q3 25
4.8%
6.2%
Q2 25
9.3%
2.5%
Q1 25
-3.6%
-6.0%
Q4 24
3.0%
5.4%
Q3 24
5.3%
-17.0%
Q2 24
9.8%
-5.3%
Capex Intensity
NUS
NUS
OEC
OEC
Q1 26
Q4 25
2.9%
11.8%
Q3 25
2.7%
9.1%
Q2 25
0.0%
9.0%
Q1 25
3.7%
6.1%
Q4 24
2.8%
16.4%
Q3 24
2.0%
10.3%
Q2 24
1.9%
11.5%
Cash Conversion
NUS
NUS
OEC
OEC
Q1 26
Q4 25
1.15×
Q3 25
1.61×
Q2 25
1.69×
5.97×
Q1 25
0.00×
0.04×
Q4 24
Q3 24
3.79×
Q2 24
1.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons